Analysts Anticipate U.S. Physical Therapy, Inc. (NYSE:USPH) Will Announce Quarterly Sales of $103.78 Million

Analysts forecast that U.S. Physical Therapy, Inc. (NYSE:USPH) will post sales of $103.78 million for…

Analysts Anticipate U.S. Physical Therapy, Inc. (NYSE:USPH) Will Announce Quarterly Sales of 3.78 Million

Analysts forecast that U.S. Physical Therapy, Inc. (NYSE:USPH) will post sales of $103.78 million for the current quarter, according to Zacks. Three analysts have made estimates for U.S. Physical Therapy’s earnings, with the highest sales estimate coming in at $105.87 million and the lowest estimate coming in at $100.40 million. U.S. Physical Therapy reported sales of $117.25 million in the same quarter last year, which would suggest a negative year over year growth rate of 11.5%. The business is expected to announce its next quarterly earnings report on Thursday, November 5th.

On average, analysts expect that U.S. Physical Therapy will report full-year sales of $413.22 million for the current financial year, with estimates ranging from $404.80 million to $417.58 million. For the next financial year, analysts expect that the business will report sales of $460.28 million, with estimates ranging from $455.62 million to $468.61 million. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that follow U.S. Physical Therapy.

U.S. Physical Therapy (NYSE:USPH) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.85 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.18) by $1.03. U.S. Physical Therapy had a return on equity of 13.36% and a net margin of 6.64%. The company had revenue of $83.86 million during the quarter, compared to the consensus estimate of $87.24 million. During the same period in the previous year, the company posted $0.81 earnings per share. U.S. Physical Therapy’s revenue for the quarter was down 33.6% on a year-over-year basis.

A number of research firms have recently commented on USPH. Zacks Investment Research upgraded U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $100.00 price objective for the company in a research report on Saturday, August 8th. ValuEngine cut U.S. Physical Therapy from a “buy” rating to a “hold” rating in a research report on Tuesday, September 1st. Finally, Barrington Research boosted their price objective on U.S. Physical Therapy from $95.00 to $100.00 and gave the company an “outperform” rating in a research report on Friday, August 7th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $93.33.

In other U.S. Physical Therapy news, CFO Lawrance W. Mcafee sold 4,450 shares of the company’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $91.41, for a total value of $406,774.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Graham D. Reeve sold 1,500 shares of the company’s stock in a transaction on Wednesday, August 12th. The shares were sold at an average price of $90.21, for a total value of $135,315.00. The disclosure for this sale can be found here. 2.00% of the stock is currently owned by insiders.

Large investors have recently modified their holdings of the business. FinTrust Capital Advisors LLC purchased a new stake in U.S. Physical Therapy in the 1st quarter valued at $37,000. Modus Advisors LLC purchased a new stake in U.S. Physical Therapy in the 2nd quarter valued at $41,000. Jane Street Group LLC purchased a new stake in U.S. Physical Therapy in the 2nd quarter valued at $203,000. ETRADE Capital Management LLC purchased a new stake in U.S. Physical Therapy in the 2nd quarter valued at $226,000. Finally, Townsquare Capital LLC grew its holdings in U.S. Physical Therapy by 47.3% in the 1st quarter. Townsquare Capital LLC now owns 3,658 shares of the company’s stock valued at $254,000 after buying an additional 1,174 shares in the last quarter.

U.S. Physical Therapy stock opened at $86.15 on Friday. The stock has a market capitalization of $1.11 billion, a PE ratio of 35.90, a price-to-earnings-growth ratio of 4.17 and a beta of 1.22. U.S. Physical Therapy has a 12 month low of $45.13 and a 12 month high of $148.48. The business has a 50 day simple moving average of $89.06 and a 200-day simple moving average of $78.25. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.05 and a quick ratio of 1.05.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Article: What is the QQQ ETF?

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy and related companies with MarketBeat.com’s FREE daily email newsletter.